MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617053002 A) filed by Cansino Biologics Inc. on April 25, 2026, for Anti-Neisseria Meningitidis Immune Composition And Use Thereof.
Inventors include Shi, Jianming; Mo, Qingshan; Zheng, Peng; Tao, Zhenmin; Zhang, Xuekuang; Tian, Wentan; Sui, Xiuwen; Deng, Jie; Xu, Qingfu; Shao, Zhongqi; and Zhu, Tao.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: Provided is an immunogenic composition. The immunogenic composition comprises at least two antigens, providing a specific combination of Neisseria meningitidis antigens, said combination being capable of enabling the immunogenic composition to have significantly improved efficacy against Neisseria meningitidis infection. The synergistic combination of the specific antigen combination achieves responses higher than the sum of responses initiated by the antigens alone. Aiming at Chinese epidemiological research, the immunogenic composition for wider coverage of MenB strains is developed.
Disclaimer: Curated by HT Syndication.
